C RYDER HOLDINGS LTD

Company number 13889942 ·

Dissolved

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

C RYDER HOLDINGS LTD - Analysis Report

Company Number: 13889942

Analysis Date: 2025-07-20 18:46 UTC

Financial Health Assessment for C RYDER HOLDINGS LTD


1. Financial Health Score: D

Explanation:
The company exhibits signs of financial distress with persistent negative net current assets and shareholders’ funds deteriorating into negative territory in the latest year. The lack of fixed assets and an ongoing net liability position suggest limited operational or investment activity. However, as a micro-entity with minimal complexity and no audit requirements, the financial structure is simple but fragile.


2. Key Vital Signs

Metric Latest Value (2025) Interpretation
Fixed Assets £0 No long-term investments or property; asset base has declined to zero, potentially reducing stability.
Current Liabilities £3 Very low short-term obligations, but still outweigh current assets resulting in negative working capital.
Net Current Assets -£3 Negative working capital indicates inability to cover short-term debts with current assets.
Total Assets Less Current Liabilities -£3 The company is technically insolvent on a net asset basis, reflecting liabilities exceeding assets.
Shareholders’ Funds -£3 Negative equity signals accumulated losses or capital withdrawals exceeding contributed capital.
Number of Employees 1 Very small operational scale, limiting revenue generation and financial resilience.

3. Diagnosis

The company shows “symptoms of distress” in its financial vital signs. Persistent negative net current assets and shareholders’ funds indicate ongoing financial weakness. The absence of fixed assets suggests no capital investment, which could limit growth prospects. The company’s micro status and minimal liabilities might mask operational challenges, but the negative equity position is a red flag akin to a patient with declining organ function.

The financial data suggests the business is either in a start-up phase with capital constraints or struggling to generate sufficient cash flow to build a sustainable asset base. The director is the sole significant controller, indicating centralized decision-making but also concentration risk.


4. Recommendations

  • Improve Liquidity: Focus on increasing current assets by improving cash reserves or receivables. This could involve accelerating customer payments or injecting additional capital.
  • Capital Injection: Consider a capital injection or shareholder loan to restore positive shareholders’ funds and strengthen the balance sheet.
  • Cost Control: Review and reduce operating expenses to conserve cash and improve profitability.
  • Asset Acquisition: Evaluate opportunities to acquire fixed assets or invest in business development to generate future revenue.
  • Regular Financial Monitoring: Implement monthly cash flow forecasts and financial reviews to catch early signs of financial strain.
  • Seek External Advice: Engage with financial advisors or business mentors to explore funding options or restructuring strategies.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.